Bias in Science Arbitration: An Authorship Viewpoint
Journal Title: Journal of Clinical Immunology & Microbiology - Year 2023, Vol 4, Issue 3
Abstract
The objective of this article was to discuss the potential bias in arbitration of unknown researchers’ scientific work in reputable journals. Publishing an article in a quality international journal is a dream that global graduate students would have. Some institutions would oblige graduate students to publish at least one article in an impactful journal before they can graduate. However, students’ efforts might lead to failure and make them disappointed. The lack of inadequacy of experience in writing scientific papers despite conducting quality research may be a sound reason for failure in timely publication. In addition, however, a major bias in arbitrating unknown authors’ science may be another reason for rejection. The second reason or challenge requires profound contemplation to be overcome. The global science is integrated and thus should be adjudicated in a fair and unbiased global scale regardless of authors’ names and institutions. To conclude, the novel content of a scientific work and not the authors’ or institutions’ reputation, must be of original importance in accepting scientific articles. Education will play pivotal roles in minimizing bias in global science arbitration.
Authors and Affiliations
Akbar Nikkhah, Masoud Alimirzaei
Keywords
Related Articles
- EP ID EP721636
- DOI http://dx.doi.org/10.46889/JCIM.2023.4303
- Views 18
- Downloads 0
Profiles of Immunoglobulin G Antibody Subclass Responses Specific to MSP3 and UB05 in Plasma of Malaria Negative Children Living in Two Different Agro-ecological Settings of Cameroon
Introduction: In malaria endemic areas, antibody specific to promising asexual blood stage malaria vaccine candidates have been demonstrated to play a critical role in protection during sub-clinical malaria. In this cont...
Genotypic Characterization of Mycobacterium Tuberculosis Strains Resistant to Rifampicin, Isoniazid and Second-Line Antibiotics in Chad
Monitoring drug resistance and identifying the genetic basis of resistance to first- and second-line anti-tuberculosis (anti-TB) drugs provides important information to optimize patient care. The present study was an...
Analysis of the Level of IgG to SARS-CoV-2 Virus and Molecular Markers of Activation of CD25, CD54 (ICAM-1) and CD95 Lymphocytes in the Patients Who were Not Ill with COVID-19, Recovered from COVID-19 and Who had Acute Respiratory Infections. The Results of the Correction of Impaired Immune Homeostasis Using the Multitarget Immunotherapy Drug Mercureid
Currently, the researchers have come across a paradox which consists in detecting protective IgG antibodies to SARS-CoV-2 virus only in a subset of patients who have recovered from COVID-19. The other patients, who were...
Morphea (Localized Scleroderma) in a COVID-19 patient: A Case Report
Since the COVID-19 pandemic raised all over the world a year ago, many dermatological manifestations have been reported in COVID-19 patients including alopecia areata, erythematous rash, widespread urticaria and chicke...
Spectroscopic Detections of Viral Infections and Their Cure with the Found Frequencies
In the ongoing pandemic, it is important to know that sick cellular culture can influence healthy cellular culture from a distance and make the healthy culture sick. The Russian scientist A.G. Gurvich first observed an...